WO2009112870A1
|
|
Pharmaceutical composition comprising rosuvastatin calcium and magnesium carbonate hydroxide pentahydrate as a stabilizer
|
HRP20050962A2
|
|
METHOD OF PREPARING (S)-(+)-METHYL α-(2-CHLORPHENYL)-6,7-DIHYDROTIENO[3,2-c]PYRIDINE-5(4H)-ACETATE HYDROGENSULFATE OF GREAT ENANTIOMER PURITY
|
HRP20040639A2
|
|
Preparation of enantiomer pure (r or s)-2-[2- ethoxymethyl]-3-ethoxycarbonyl-4-(2-chlorphenyl)-5- by separation of racemate in chiral inactive phases
|
HRP20040520A2
|
|
Resolution (r,s)-2-(2-aminoethoxymethyl)-3-ethoxycarbonyl-4-(2-chlorphenyl)-5-methoxycarbonyl-6-methyl-1,4- dihydropiridine lipase catalysed
|
HRP20031029A2
|
|
Process for production of inclusion complexes of valsartan with?-cylodextrin
|
HRP20030998A2
|
|
Process for production of 2n-trithyl-5-(4'-methylbiphenilenyl-2-yl)tetrazole
|
HRP20030965A2
|
|
Process for production of (s)-n-pentanoyl-n-[[2'-(
|
HRP20030864A2
|
|
METHOD FOR PREPARATION OF METHYL-α-(2-CHLOROPHENYL)-6,7-DIHYDROTIENO[3,2-c]PIRIDINE-5(4H)-ACETATE
|
HRP20020571A2
|
|
Method for preparation of enantiomere free atenolol using preparative chromatography on chiral static phase
|
HRP20020418A2
|
|
Process for preparation of acyclovir
|
HRP20020024A2
|
|
Process for the preparation of fluoxetine
|
HRP20010543A2
|
|
Process for the preparation of pyroxycam and beta-cyclodextrine complex
|
HRP20010190A2
|
|
Process for the preparation of alpha-arbutine
|
HRP20010081A2
|
|
PROCESS FOR THE PREPARATION OF 4h-s-TRIAZOLO (4,3-ALPHA)(1,4)-BENZODIAZEPINE, ALPRAZOLAM AND TRIAZOLAM
|
HRP20000802A2
|
|
Process for the preparation of 3-hydroxy-1,4-benzodiazepine, oxazepam and lorazepam
|
HRP20000761A2
|
|
Preparations of biologically active 3,7- and 1,7- dibromdibenzosuberone derivatives
|
HRP20000680A2
|
|
Process for the preparation of fluconazole
|
HRP20000490A2
|
|
Process for the preparation of amlodipine besilate
|
HRP20000279A2
|
|
Process for the preparation of sildenaphyl and intermediates
|
HRP20000095A2
|
|
Process for preparing a pure atenolol enantiomer
|